Herbal Center (NYSE:HLF) issued an update on its second quarter earnings guidance on Thursday morning. The company provided EPS guidance of $1.15-1.35 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.52. The company issued revenue guidance of +8.5-12.5% to ~$1.24-1.29 billion, compared to the consensus revenue estimate of $1.24 billion.Herbal Center also updated its FY18 guidance to $5.05-5.45 EPS.
HLF has been the topic of a number of recent research reports. TheStreet lowered Herbal Center from a b- rating to a c rating in a research report on Monday, March 5th. SunTrust Banks upped their target price on Herbal Center to $52.50 and gave the company a hold rating in a research report on Friday, May 4th. ValuEngine raised Herbal Center from a buy rating to a strong-buy rating in a report on Thursday, March 1st. Citigroup reaffirmed a neutral rating and issued a $42.50 target price (up previously from $36.50) on shares of Herbal Center in a report on Thursday, February 22nd. Finally, Zacks Investment Research cut Herbal Center from a buy rating to a sell rating in a research note on Wednesday, March 28th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the stock. The company has an average rating of Buy and a consensus target price of $58.00.
NYSE:HLF traded up $0.17 during trading hours on Friday, reaching $53.39. The stock had a trading volume of 27,951 shares, compared to its average volume of 2,432,796. The company has a market capitalization of $9.71 billion, a P/E ratio of 21.90 and a beta of 1.19. Herbal Center has a 12-month low of $54.74 and a 12-month high of $55.24. The company has a debt-to-equity ratio of -9.63, a current ratio of 2.14 and a quick ratio of 1.78.
In other news, EVP Henry C. Wang sold 332 shares of the business’s stock in a transaction that occurred on Friday, May 11th. The stock was sold at an average price of $111.46, for a total value of $37,004.72. Following the sale, the executive vice president now directly owns 3,388 shares of the company’s stock, valued at approximately $377,626.48. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Jossie Aspauza sold 9,995 shares of the business’s stock in a transaction that occurred on Wednesday, February 28th. The stock was sold at an average price of $90.38, for a total value of $903,348.10. Following the completion of the sale, the vice president now directly owns 14,592 shares in the company, valued at $1,318,824.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 102,112 shares of company stock worth $9,926,134. 6.19% of the stock is owned by company insiders.
Herbal Center Company Profile
Herbalife Ltd. develops and sells nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. It provides science-based products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition.
Receive News & Ratings for Herbal Center Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbal Center and related companies with MarketBeat.com's FREE daily email newsletter.